Marc Rothenberg

Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.

Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.

In conversation with... Marc Rothenberg

Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.

Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.

In conversation with... Michael Pavlides

Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.

Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.

In conversation with... Jasmohan Bajaj

Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender.

Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender.

In conversation with... Adelina Artenie

Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology &amp; Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.

Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology &amp; Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.

In conversation with... Johan Burisch

Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.

Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.

In conversation with... Edouard Louis

Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma.

Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma.

In conversation with... Paula Ghaneh

Dan Turner

Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.

Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.

In conversation with... Dan Turner

Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.

Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.

In conversation with... Simon Baunwall

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

In conversation with... James Alexander

The Lancet Gastroenterology &amp; Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

Listen to The Lancet Gastroenterology &amp; Hepatology

Jennifer Flemming talks with The Lancet Gastroenterology &amp; Hepatology about recent developments in the field of chronic liver disease.

Jennifer Flemming talks with The Lancet Gastroenterology &amp; Hepatology about recent developments in the field of chronic liver disease.

Epidemiology of chronic liver disease

Magnus Simrén comprehensively reviews treatments and therapies for irritable bowel syndrome.

Magnus Simrén comprehensively reviews treatments and therapies for irritable bowel syndrome.

Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017

Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis

Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis

Statins and decompensated cirrhosis

Dr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition.

Dr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition.

Treating faecal incontinence in women

Gil Kaplan discusses the rise of IBD in countries that don't have a history of the disease.

Gil Kaplan discusses the rise of IBD in countries that don't have a history of the disease.

Inflammatory bowel disease: The Lancet Gastroenterology & Hepatology: December issue

Mohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer.

Mohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer.

Global burden of pancreatic cancer and colorectal cancer

Pere Ginès from the Liver Unit at the Hospital Clinic in Barcelona, Spain, discusses a Viewpoint for liver fibrosis screening in the general population.

Pere Ginès from the Liver Unit at the Hospital Clinic in Barcelona, Spain, discusses a Viewpoint for liver fibrosis screening in the general population.

Liver fibrosis screening: The Lancet Gastroenterology & Hepatology: October 12, 2016

Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.

Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.

A new drug for short bowel syndrome

Leo Katsidzira talks about the epidemiology of colorectal cancer in sub-Saharan Africa.

Leo Katsidzira talks about the epidemiology of colorectal cancer in sub-Saharan Africa.

Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017

Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.

Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.

Acute hepatitis C

Stuart Taylor discusses the results of the STREAMLINE trials, which assessed the use of whole-body MRI to stage colorectal and lung cancers.

Stuart Taylor discusses the results of the STREAMLINE trials, which assessed the use of whole-body MRI to stage colorectal and lung cancers.

Whole-body MRI: the STREAMLINE trials

Viktor Wintzell joins The Lancet Gastroenterology &amp; Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.

Viktor Wintzell joins The Lancet Gastroenterology &amp; Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.

Paediatric inflammatory bowel disease

Michele Reni speaks with The Lancet Gastroenterology &amp; Hepatology about the PAXG regimen for treatment of pancreatic cancer.

Michele Reni speaks with The Lancet Gastroenterology &amp; Hepatology about the PAXG regimen for treatment of pancreatic cancer.

Pancreatic cancer treatment

Philippa Easterbrook discusses a series of two Review articles on viral hepatitis in children and adolescents.

Philippa Easterbrook discusses a series of two Review articles on viral hepatitis in children and adolescents.

Viral hepatitis in children & adolescents

Dr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS.

Dr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS.

Faecal microbiota transplantation in IBS

Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

DAA treatment for hepatitis C among people who inject drugs

Rebecca Fitzgerald discusses her paper on risk stratification for patients with Barrett's oesophagus.

Rebecca Fitzgerald discusses her paper on risk stratification for patients with Barrett's oesophagus.

Barrett's oesophagus: The Lancet Gastroenterology & Hepatology: Jan 2017

As part of The Lancet Gastroenterology &amp; Hepatology’s April issue, Nigel Hall discusses the CHINA trial of observation versus interval appendicectomy for children with an appendix mass.

As part of The Lancet Gastroenterology &amp; Hepatology’s April issue, Nigel Hall discusses the CHINA trial of observation versus interval appendicectomy for children with an appendix mass.

Treatment of an appendix mass in children: The Lancet Gastroenterology & Hepatology: March 8, 2017

Naveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it.

Naveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it.

Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017

Prof Raymond Chung discusses new research in transplantation of HCV-infected hearts.

Prof Raymond Chung discusses new research in transplantation of HCV-infected hearts.

Transplanting hepatitis C-infected hearts

The best podcasts about ourselves as well as the world through the lense of Science. Specific topics include things about our brain, emotions to biology, physics and more!

Best Episodes on Science, Humans & The World

The best podcast episodes of the most interesting stories and things. From skyping someone while they're in space, to tracking down and meeting a telephone scammer in person, to the story of a Galapagos. These episodes will keep you and all your friends entertained and captivated for hours. Learn something new in every episode! Add episodes you're interested into your queue below!

Listen to The Lancet Gastroenterology &amp; Hepatology

Listen to The Lancet Gastroenterology & Hepatology